| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 2 securities · passive | ||||||
|
Septerna, Inc.
13G/A
SEPN · 81734D104
|
13.0% |
11/16/2026
Event 9/30/2026
|
||||
| Third Rock Ventures V, L.P. | 13.0% | |||||
| Third Rock Ventures GP V, L.P. | 13.0% | |||||
| TRV GP V, LLC | 13.0% | |||||
| Third Rock Ventures VI, L.P. | 9.0% | |||||
| Third Rock Ventures GP VI, L.P. | 9.0% | |||||
| TRV GP VI, LLC | 9.0% | |||||
|
Rapport Therapeutics, Inc.
13G/A
RAPP · 75383L102
|
13.1% |
8/14/2026
Event 6/30/2026
|
||||
| Third Rock Ventures V, L.P. | 13.1% | |||||
| Third Rock Ventures GP V, L.P. | 13.1% | |||||
| TRV GP V, LLC | 13.1% | |||||
| Third Rock Ventures VI, L.P. | 2.0% | |||||
| Third Rock Ventures GP VI, L.P. | 2.0% | |||||
| TRV GP VI, LLC | 2.0% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.